Drug Shortage Report for DIAZEPAM
| Report ID | 20866 |
| Drug Identification Number | 00362158 |
| Brand name | APO DIAZEPAM TAB 5MG |
| Common or Proper name | DIAZEPAM |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DIAZEPAM |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1000 BTL |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-10-31 |
| Actual start date | 2017-10-25 |
| Estimated end date | 2017-11-30 |
| Actual end date | 2017-10-25 |
| Shortage status | Avoided shortage |
| Updated date | 2017-10-31 |
| Company comments | 100 BTL AVAILABLE |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-09-04 | English | Compare |
| v2 | 2017-09-04 | French | Compare |
| v3 | 2017-10-31 | English | Compare |
| v4 | 2017-10-31 | French | Compare |
| v5 | 2017-10-31 | English | Compare |
| v6 | 2017-10-31 | French | Compare |
Showing 1 to 6 of 6